Center for Scientific Review; Notice of Closed Meetings, 24726 [2012-9908]
Download as PDF
<![CDATA[
24726
Federal Register / Vol. 77, No. 80 / Wednesday, April 25, 2012 / Notices
pmangrum on DSK3VPTVN1PROD with NOTICES
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Neurological Disorders and Stroke Council.
Date: May 24–25, 2012.
Open: May 24, 2012, 8 a.m. to 2:15 p.m.
Agenda: Report by the Director, NINDS;
Report by the Associate Director for
Extramural Research; Administrative and
Program Developments; and an Overview of
the NINDS Intramural Program.
Place: National Institutes of Health,
Building 31, 31 Center Drive, C Wing,
Conference Room 10, Bethesda, MD 20892.
Closed: May 24, 2012, 2:15 p.m. to 4:15
p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, C Wing,
Conference Room 10, Bethesda, MD 20892.
Closed: May 24, 2012, 4:15 p.m. to 4:45
p.m.
Agenda: To review and evaluate the
Division of Intramural Research Board of
Scientific Counselors’ Reports.
Place: National Institutes of Health,
Building 31, 31 Center Drive, C Wing,
Conference Room 10, Bethesda, MD 20892.
Closed: May 25, 2012, 8 a.m. to 11 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, C Wing,
Conference Room 10, Bethesda, MD 20892.
Contact Person: Robert Finkelstein, Ph.D.,
Associate Director for Extramural Research,
National Institute of Neurological Disorders
and Stroke, NIH, 6001 Executive Blvd., Suite
3309, MSC 9531, Bethesda, MD 20892, (301)
496–9248.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https:///
www.ninds.nih.gov, where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
VerDate Mar<15>2010
15:14 Apr 24, 2012
Jkt 226001
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS).
Dated: April 17, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–9910 Filed 4–24–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA Panel:
Investigations on Primary Immunodeficiency
Diseases.
Date: May 14, 2012.
Time: 12 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Scott Jakes, Ph.D.,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4198,
MSC 7812, Bethesda, MD 20892, 301–495–
1506, jakesse@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflicts: Asthma, inflammation, and airway
smooth muscle applications.
Date: May 15, 2012.
Time: 12:30 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Everett E Sinnett, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2178,
MSC 7818, Bethesda, MD 20892, 301–435–
1016, sinnett@nih.gov.
Name of Committee: Surgical Sciences,
Biomedical Imaging and Bioengineering
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
Integrated Review Group; Bioengineering,
Technology and Surgical Sciences Study
Section.
Date: May 21–22, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Hotel, One Bethesda
Metro Center, Bethesda, MD 20814.
Contact Person: Khalid Masood, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5120,
MSC 7854, Bethesda, MD 20892, 301–435–
2392, masoodk@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: April 18, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–9908 Filed 4–24–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse
and Alcoholism; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Advisory Council on Alcohol
Abuse and Alcoholism.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council on Alcohol Abuse and Alcoholism.
Date: June 6–7, 2012.
Closed: June 6, 2012, 5 p.m. to 7:30 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\25APN1.SGM
25APN1
]]>Agencies
[Federal Register Volume 77, Number 80 (Wednesday, April 25, 2012)]
[Notices]
[Page 24726]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-9908]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; RFA Panel: Investigations on Primary Immunodeficiency
Diseases.
Date: May 14, 2012.
Time: 12 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Scott Jakes, Ph.D., Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4198, MSC 7812, Bethesda, MD
20892, 301-495-1506, jakesse@mail.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflicts: Asthma, inflammation, and airway smooth
muscle applications.
Date: May 15, 2012.
Time: 12:30 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Everett E Sinnett, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2178, MSC 7818, Bethesda, MD
20892, 301-435-1016, sinnett@nih.gov.
Name of Committee: Surgical Sciences, Biomedical Imaging and
Bioengineering Integrated Review Group; Bioengineering, Technology
and Surgical Sciences Study Section.
Date: May 21-22, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Hotel, One Bethesda Metro Center, Bethesda,
MD 20814.
Contact Person: Khalid Masood, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5120, MSC 7854, Bethesda, MD 20892, 301-435-
2392, masoodk@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: April 18, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-9908 Filed 4-24-12; 8:45 am]
BILLING CODE 4140-01-P
